Therapeutic angiogenesis with acidic gelatin hydrogel microspheres incorporating fibroblast growth factor-2 for intermittent claudicatio
Not Applicable
- Conditions
- Arteriosclerosis obliterance
- Registration Number
- JPRN-C000000201
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1.Hypersensitivity for gelatin hydrogel 2.Serious medical co-morbidities 3.Alcoholism or other drug dependence within 3 months 4.Malignancy within 5 years 5.Possibility of malignancy 6.Operations within 3 months 7.Severe diabetic retinopathy 8.Pregnant woman, lactating woman 9.Vascular reconstruction within 2 months 10.Other complication unsuitable for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method